James Edgemond, CFO AND TREASURER at UNITED THERAPEUTICS Corp (UTHR), sold 10,000 shares at $544.93 ($5.5M) on 2026-06-08, disclosed to the SEC on 2026-06-09.
Scheduled sale ($5.5M) by CFO AND TREASURER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $544.93 | 1,565 | $853K | 15.6% |
| 2 | $546.13 | 1,989 | $1.1M | 19.8% |
| 3 | $547.03 | 1,888 | $1.0M | 18.9% |
| 4 | $547.91 | 2,158 | $1.2M | 21.6% |
| 5 | $549.38 | 425 | $233K | 4.3% |
| 6 | $550.09 | 1,285 |
| $707K |
| 12.9% |
| 7 | $551.28 | 610 | $336K | 6.1% |
| 8 | $551.75 | 80 | $44K | 0.8% |
| Total | $547.50 avg | 10,000 | $5.5M | 100% |
| Filing → |
| UTHR | SELL | 2026-06-16 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-12 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-05 | $5.5M | — | Filing → |